References
Coma MC, Sobrin L, Onal S, et al. Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology 2007;114: 1574–1579.
Ziemsson F, Deuter CM, Stuebiger N, Zierhut M. Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 2007;245: 917–918.
Mackensen F, Heinz C, Becker MD, Heiligenhaus A. Intravitreal bevacizumab (Avastin) as a treatment for refractory macular edema in patients with uveitis. Retina 2008;28:41–45.
Mansour AM, Mackensen F, Arevalo JF, et al. Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2008;146:410–416.
Pieramici DJ, Avery RL, Castellarin AA, et al. Case of anterior uveitis after intravitreal injection of bevacizumab. Retina 2006; 26:841–842.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Okada, A.A., Keino, H., Watanabe, T. et al. Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis. Jpn J Ophthalmol 53, 182–184 (2009). https://doi.org/10.1007/s10384-008-0637-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0637-4